Skip to content

Epicel (cultured epidermal autografts) N/ARecalls & reported problems

Vericel Corporation · Epicel (cultured epidermal autografts) is an aseptically processed wound dressing composed of the patient’s own (autologous) keratinocytes grown ex vivo in the presence of proliferation-arrested, murine (mouse) fibroblasts. Epicel consists of sheets of proliferative, autologous keratinocytes, ranging from 2 to 8 cell layers thick and is referred to as a cultured epidermal autograft. Each graft of Epicel is attached to petrolatum gauze backing with titanium surgical clips and measures a minimum of 50 cm2 in area. Epicel is authorized by Federal law for use in adult and pediatric patients who have deep dermal or full-thickness burns comprising a total body surface area greater than or equal to 30%. Epicel may be used in conjunction with split-thickness autografts, or alone in patients for whom split-thickness autografts may not be an option due to the severity and extent of their burns. · Class f · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
3
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI W41020AU201S1969), received between Aug 13, 2024 and Nov 7, 2025 — classified as 3 deaths, 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Product Quality Problem” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Product Quality Problem2
  • Leak/Splash1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • Atrial Fibrillation1
  • Coagulation Disorder1
  • Disseminated Intravascular Coagulation (DIC)1
  • Hemorrhage/Blood Loss/Bleeding1
  • Sepsis1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 7, 2025Product Quality Problem; Product Quality Problem

    12 GRAFTS WERE RUNNY AND UNUSABLE DUE TO THE CELLS SLIDING OFF THE BACKING WITH THE CONSISTENCY OF SNOT [PRODUCT QUALITY ISSUE].

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23494538 ↗
  • DeathApr 1, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ISCHEMIC BOWEL DISEASE [INTESTINAL ISCHAEMIA].

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

    MAUDE report 21738872 ↗
  • DeathJan 14, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PULMONARY HEMORRHAGE [PULMONARY HAEMORRHAGE] MEDICATION REFRACTORY ATRIAL FIBRILLATION [ATRIAL FIBRILLATION] TRANSFUSION-ASSOCIATED RELATED THROMBOCYTOPENIA [THROMBOCYTOPENIA] SEPSIS [SEPSIS].

    Patient problems: Atrial Fibrillation; Coagulation Disorder; Hemorrhage/Blood Loss/Bleeding; Sepsis

    MAUDE report 21147255 ↗
  • DeathNov 27, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    DISSEMINATED INTRAVASCULAR COAGULATION (DIC) [DISSEMINATED INTRAVASCULAR COAGULATION].

    Patient problems: Disseminated Intravascular Coagulation (DIC)

    MAUDE report 20794715 ↗
  • MalfunctionAug 13, 2024Leak/Splash; Product Quality Problem; Leak/Splash; Product Quality Problem

    LOOSE PINK LIQUID WAS NOTED ON THE OUTSIDE OF THE CARTRIDGES IN ONE SLEEVE OF TRAYS [PRODUCT LEAKAGE].

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19971238 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page